Composition BPC-157: 20 mg Appearance: Lyophilized powder in a sealed research vial Research Focus (non-clinical) Peptide identity and purity assessment Assay development and calibration for quantitative analysis Chromatographic method optimization for impurity profiling Stability characterization of a lyophilized peptide under laboratory storage conditions Documentation Lot-specific COA available Batch and lot traceability Important Notice For research use only Not for human consumption Not intended to diagnose, treat, cure, or prevent any disease Quality & Manufacturing Lot-specific COA Lyophilized for transit stability
Clinical Update 3/28/2023 Protein For Faster Improvement
3 AgmonE.SolonJ.BassereauP.StockwellB
Schedule: Daily subcutaneous injections for 1226 weeks (extendable to 52 weeks with medical supervision) [3]
Ethoxydiglycol, 3-O-Ethyl Ascorbic Acid, Tetrahexyldecyl Ascorbate, Dimethyl Isosorbide, Isodecyl Neopentanoate, Glutathione (L), Superoxide Dismutase, Ethylhexylglycerin, Caprylyl Glycol, Phenoxyethanol